JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Johnson & Johnson's quarterly cash and cash equivalents declined from Dec. 2013 ($20,927 Mil) to Mar. 2014 ($19,722 Mil) and declined from Mar. 2014 ($19,722 Mil) to Jun. 2014 ($14,236 Mil).
Johnson & Johnson's annual cash and cash equivalents declined from Dec. 2011 ($24,542 Mil) to Dec. 2012 ($14,911 Mil) but then increased from Dec. 2012 ($14,911 Mil) to Dec. 2013 ($20,927 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Johnson & Johnson Annual Data
Johnson & Johnson Quarterly Data